DEFINING NEW THERAPEUTICS USING A MORE IMMUNOCOMPETENT MOUSE MODEL OF ANTIBODY-ENHANCED DENGUE VIRUS INFECTION



Account has been disabled due to a violation of Terms of Service.

Contact Moderators